{"organizations": [], "uuid": "7791eec555c825ac506bf9ee4c7d22721b553e90", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-bausch-lomb-says-fda-approved-ultr/brief-bausch-lomb-says-fda-approved-ultra-family-of-contact-lenses-for-extended-wear-idUSASC09YZR", "country": "US", "domain_rank": 408, "title": "BRIEF-Bausch + Lomb Says FDA Approved Ultra Family Of Contact Lenses For Extended Wear", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-05-02T15:45:00.000+03:00", "replies_count": 0, "uuid": "7791eec555c825ac506bf9ee4c7d22721b553e90"}, "author": "", "url": "https://www.reuters.com/article/brief-bausch-lomb-says-fda-approved-ultr/brief-bausch-lomb-says-fda-approved-ultra-family-of-contact-lenses-for-extended-wear-idUSASC09YZR", "ord_in_thread": 0, "title": "BRIEF-Bausch + Lomb Says FDA Approved Ultra Family Of Contact Lenses For Extended Wear", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "valeant pharmaceuticals international inc", "sentiment": "none"}, {"name": "contact lenses for extended wear reuters staff", "sentiment": "none"}, {"name": "bausch", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "May 2, 2018 / 12:45 PM / Updated 15 minutes ago BRIEF-Bausch + Lomb Says FDA Approved Ultra Family Of Contact Lenses For Extended Wear Reuters Staff\nMay 2 (Reuters) - Valeant Pharmaceuticals International Inc :\n* BAUSCH + LOMB ULTRAÂ® CONTACT LENSES RECEIVE FDA APPROVAL FOR EXTENDED WEAR INDICATION\n* BAUSCH + LOMB SAYS U.S. FDA APPROVED BAUSCH + LOMB ULTRA FAMILY OF CONTACT LENSES FOR EXTENDED WEAR OF UP TO 6 NIGHTS & 7 DAYS OF CONTINUOUS WEAR Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-05-02T15:45:00.000+03:00", "crawled": "2018-05-02T16:03:34.019+03:00", "highlightTitle": ""}